+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Monodox"

Doxycycline Hyclate Capsules Market - Global Forecast 2025-2030 - Product Thumbnail Image

Doxycycline Hyclate Capsules Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 197 Pages
  • Global
From
  • 1 Results (Page 1 of 1)
Loading Indicator

Monodox is a brand of doxycycline, an antibiotic used to treat a variety of bacterial infections. It is commonly used to treat respiratory infections such as bronchitis, pneumonia, and sinusitis. It is also used to treat acne, Lyme disease, and other bacterial infections. Monodox is available in both oral and topical forms. The oral form is taken as a pill or capsule, while the topical form is applied directly to the skin. Monodox is part of the larger respiratory drug market, which includes antibiotics, anti-inflammatory drugs, and bronchodilators. These drugs are used to treat a variety of respiratory conditions, including asthma, COPD, and other chronic respiratory diseases. The Monodox market is highly competitive, with many companies offering similar products. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, and Novartis. Other companies include Sanofi, AstraZeneca, and Teva Pharmaceuticals. Show Less Read more